Kevin McNerney: Clinical Trials

1 trial sponsored by Kevin McNerney, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Kevin McNerney: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pre-emptive Anakinra for Cytokine Event Reduction
Anakinra (Kineret®) - B-Acute Lymphoblastic Leukemia, CAR-T Cell Therapy
Phase 1 / Phase 2WithdrawnKevin McNerney2026-10-012026-08-13

Conditions studied

Burkitt Lymphoma (1)  ·  Cytokine Release Syndrome (1)

Interventions

Interleukin 1 Receptor Antagonist Protein (1)

Countries

United States (1)

NIH funding

K12TR005104 (1)